{"id":13974,"date":"2024-05-12T04:25:00","date_gmt":"2024-05-12T08:25:00","guid":{"rendered":"https:\/\/www.rigicon.com\/uncategorized\/new-study-confirms-first-safety-outcomes-of-contireflex-artificial-urinary-sphincter-for-treating-male-incontinence-2\/"},"modified":"2024-05-12T04:25:00","modified_gmt":"2024-05-12T08:25:00","slug":"new-study-confirms-first-safety-outcomes-of-contireflex-artificial-urinary-sphincter-for-treating-male-incontinence","status":"publish","type":"post","link":"https:\/\/www.rigicon.com\/pt-br\/comunicados-de-imprensa\/new-study-confirms-first-safety-outcomes-of-contireflex-artificial-urinary-sphincter-for-treating-male-incontinence\/","title":{"rendered":"Novo estudo confirma os primeiros resultados de seguran\u00e7a do ContiReflex\u00ae\u00a0esf\u00edncter urin\u00e1rio artificial no tratamento da incontin\u00eancia masculina"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Rigicon orgulhosamente anuncia a publica\u00e7\u00e3o do artigo do estudo cl\u00ednico intitulado \u201cPrimeiros resultados de seguran\u00e7a de ContiReflex<sup>\u00ae\u00a0<\/sup>esf\u00edncter urin\u00e1rio artificial para tratamento da incontin\u00eancia masculina\u201d.<\/p>\n\n\n<p class=\"wp-block-paragraph\">ContiReflex<sup>\u00ae<\/sup>\u00a0demonstrou oferecer resultados de seguran\u00e7a compar\u00e1veis \u200b\u200ba outros dispositivos no mercado.<\/p>\n\n\n<p class=\"wp-block-paragraph\">Abrangendo de abril de 2022 a outubro de 2023, o estudo envolveu os primeiros 50 pacientes que receberam o ContiReflex<sup>\u00ae<\/sup>\u00a0dispositivo. A maioria dos pacientes foi submetida \u00e0 prostatectomia radical, com idade variando de 57 a 84 anos.<\/p>\n\n\n<p class=\"wp-block-paragraph\">ContiReflex<sup>\u00ae<\/sup>\u00a0apresentou um alto n\u00edvel de seguran\u00e7a e confiabilidade operacional, evidenciado por uma taxa de sobreviv\u00eancia de 98% 18 meses ap\u00f3s a implanta\u00e7\u00e3o. Notavelmente, o dispositivo exigiu revis\u00f5es cir\u00fargicas m\u00ednimas, enfatizando sua precis\u00e3o e efic\u00e1cia na aplica\u00e7\u00e3o cl\u00ednica.<\/p>\n\n\n<p class=\"wp-block-paragraph\"><em>Dados sobre os \u201cResultados iniciais de seguran\u00e7a do ContiReflex<sup>\u00ae\u00a0<\/sup>esf\u00edncter urin\u00e1rio artificial para o tratamento da incontin\u00eancia masculina\u201d foram apresentados na Reuni\u00e3o Anual da American Urological Association de 2024 em San Antonio, Texas, EUA.<\/em><\/p>\n\n\n<p class=\"wp-block-paragraph\">ContiReflex<sup>\u00ae<\/sup>\u00a0esf\u00edncter urin\u00e1rio artificial aprimorado (AUS), um novo dispositivo desenvolvido por Rigicon, est\u00e1 sendo usado para tratar incontin\u00eancia urin\u00e1ria devido \u00e0 defici\u00eancia intr\u00ednseca do esf\u00edncter em casos como incontin\u00eancia ap\u00f3s cirurgia de pr\u00f3stata.<\/p>\n\n\n<p class=\"wp-block-paragraph\">Ao contr\u00e1rio dos dispositivos tradicionais, o ContiReflex<sup>\u00ae<\/sup>\u00a0com seu bal\u00e3o com reflexo inteligente detecta constantemente mudan\u00e7as na press\u00e3o intra-abdominal e adapta simultaneamente a press\u00e3o na uretra, potencialmente ajudando os pacientes a permanecerem secos de forma mais consistente.<\/p>\n\n\n<p class=\"wp-block-paragraph\">O design exclusivo de dois componentes do ContiReflex permite que o sistema ajuste a press\u00e3o do manguito em tempo real, com base nas altera\u00e7\u00f5es da press\u00e3o intra-abdominal. Isto significa que pode potencialmente alcan\u00e7ar resultados de contin\u00eancia satisfat\u00f3rios com uma press\u00e3o basal mais baixa do que os dispositivos tradicionais.<\/p>\n\n\n<p class=\"wp-block-paragraph\">Os novos tamanhos de manguitos oferecem aos cirurgi\u00f5es uma variedade de op\u00e7\u00f5es de manguitos oclusivos, dispon\u00edveis em tamanhos incrementais de 0,25 cm, variando de 3,5 a 5 cm, para um ajuste personalizado \u00e0 anatomia uretral do paciente.<\/p>\n\n\n<p class=\"wp-block-paragraph\">Ao contr\u00e1rio de outros dispositivos no mercado, ContiReflex<sup>\u00ae<\/sup>\u00a0\u00e9 fabricado exclusivamente com revestimento hidrof\u00edlico HydroShield\u2122 em todas as superf\u00edcies externas, incluindo o bal\u00e3o regulador de press\u00e3o. O revestimento HydroShield\u2122 permite diversas op\u00e7\u00f5es de imers\u00e3o, possibilitando uma abordagem personalizada para atender \u00e0s necessidades espec\u00edficas do cirurgi\u00e3o e do paciente.<\/p>\n\n\n<p class=\"wp-block-paragraph\"><strong>Sobre incontin\u00eancia urin\u00e1ria<\/strong><\/p>\n\n\n<p class=\"wp-block-paragraph\">A incontin\u00eancia urin\u00e1ria (IU) \u00e9 a perda involunt\u00e1ria de urina. Pacientes que sofrem de incontin\u00eancia urin\u00e1ria n\u00e3o conseguem controlar a libera\u00e7\u00e3o de urina da bexiga. Embora incontin\u00eancia urin\u00e1ria de esfor\u00e7o (IUE) seja o tipo mais comum, existem diferentes tipos de incontin\u00eancia urin\u00e1ria. A incontin\u00eancia urin\u00e1ria de esfor\u00e7o \u00e9 o vazamento inesperado de urina quando ocorre uma press\u00e3o externa com atividades como levantar peso, tossir, espirrar, rir ou fazer exerc\u00edcios. Essa press\u00e3o externa faz com que a bexiga j\u00e1 enfraquecida vaze urina.<\/p>\n\n\n<p class=\"wp-block-paragraph\">Os esf\u00edncteres urin\u00e1rios enfraquecidos podem ser causados \u200b\u200bpor: Cirurgia na regi\u00e3o p\u00e9lvica ou na pr\u00f3stata, les\u00e3o na uretra, medicamentos, excesso de peso, altera\u00e7\u00f5es com a idade e outras causas. A incontin\u00eancia urin\u00e1ria \u00e9 um problema significativo, afetando dezenas de milh\u00f5es de pacientes. Estima-se que a IU afete 1 em cada 10 homens, com preval\u00eancia crescente associada ao envelhecimento.<\/p>\n\n\n<p class=\"wp-block-paragraph\">Homens com incontin\u00eancia urin\u00e1ria apresentam uma taxa mais elevada de depress\u00e3o e s\u00e3o mais propensos a diminuir a participa\u00e7\u00e3o em atividades (por exemplo, diminuir as horas de trabalho, mudar de emprego ou reformar-se voluntariamente antecipadamente).<\/p>\n\n\n<p class=\"wp-block-paragraph\"><strong>Sobre esf\u00edncter urin\u00e1rio artificial<\/strong><\/p>\n\n\n<p class=\"wp-block-paragraph\">esf\u00edncter urin\u00e1rio artificial (AUS) \u00e9 um dispositivo m\u00e9dico projetado especificamente para tratar a incontin\u00eancia urin\u00e1ria. Um esf\u00edncter urin\u00e1rio artificial \u00e9 uma op\u00e7\u00e3o de tratamento cir\u00fargico quando as op\u00e7\u00f5es de tratamento n\u00e3o cir\u00fargico ou comportamental falham.<\/p>\n\n\n<p class=\"wp-block-paragraph\">AUS imitar\u00e1 o papel de um esf\u00edncter urin\u00e1rio saud\u00e1vel (os dois m\u00fasculos que controlam a sa\u00edda da urina da bexiga atrav\u00e9s da uretra) fechando a uretra e evitando o vazamento de urina. O paciente apertar\u00e1 uma bomba localizada no escroto para liberar o manguito sobre a uretra e esvaziar. A bra\u00e7adeira retornar\u00e1 ao estado fechado em cerca de 2 minutos para evitar vazamento de urina ap\u00f3s a mic\u00e7\u00e3o.<\/p>\n\n\n<p class=\"wp-block-paragraph\">O esf\u00edncter urin\u00e1rio artificial \u00e9 amplamente considerado o padr\u00e3o ouro para o tratamento da incontin\u00eancia urin\u00e1ria.<\/p>\n\n\n<p class=\"wp-block-paragraph\"><strong>Sobre Rigicon<\/strong><\/p>\n\n\n<p class=\"wp-block-paragraph\">Rigicon \u00e9 especializada em pesquisa, desenvolvimento e fabrica\u00e7\u00e3o de solu\u00e7\u00f5es prot\u00e9ticas urol\u00f3gicas inovadoras, com 30 anos de experi\u00eancia em urologia. Rigicon continua a introduzir tecnologias de ponta que melhoram os resultados dos pacientes e melhoram a qualidade de vida daqueles que sofrem de problemas urin\u00e1rios, incluindo disfun\u00e7\u00e3o er\u00e9til e incontin\u00eancia urin\u00e1ria. O compromisso da Rigicon com a inova\u00e7\u00e3o e o atendimento ao paciente continua a redefinir os padr\u00f5es da ind\u00fastria e a melhorar a qualidade de vida dos pacientes em todo o mundo.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Rigicon orgulhosamente anuncia a publica\u00e7\u00e3o do artigo do estudo cl\u00ednico intitulado \u201cPrimeiros resultados de seguran\u00e7a de ContiReflex\u00ae\u00a0esf\u00edncter urin\u00e1rio artificial para tratamento da incontin\u00eancia masculina\u201d. ContiReflex\u00ae\u00a0demonstrou oferecer resultados de seguran\u00e7a compar\u00e1veis \u200b\u200ba outros dispositivos no mercado. Abrangendo de abril de 2022 a outubro de 2023, o estudo envolveu os primeiros 50 pacientes que receberam o ContiReflex\u00ae\u00a0dispositivo. [&hellip;]<\/p>\n","protected":false},"author":0,"featured_media":7215,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[822],"tags":[],"class_list":["post-13974","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-comunicados-de-imprensa"],"acf":{"ce_paper_title":"","ce_year":2024,"ce_journal":"O Jornal de Urologia","ce_doi":"","ce_summary":"","ce_authors":"","ce_objective":"","ce_key_findings":"","ce_conclusion":"","ce_clinical_relevance":"","ce_pdf":null,"ce_logos":null,"ce_featured":false,"ce_keywords":""},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.9 (Yoast SEO v27.9) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>ContiReflex AUS Safety Outcomes Study | Rigicon<\/title>\n<meta name=\"description\" content=\"O estudo de Rigicon sobre ContiReflex\u00ae para incontin\u00eancia masculina mostra uma taxa de sobreviv\u00eancia de 98% em 18 meses, com revis\u00f5es m\u00ednimas, demonstrando sua seguran\u00e7a e efic\u00e1cia.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.rigicon.com\/pt-br\/comunicados-de-imprensa\/new-study-confirms-first-safety-outcomes-of-contireflex-artificial-urinary-sphincter-for-treating-male-incontinence\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Novo estudo confirma os primeiros resultados de seguran\u00e7a do ContiReflex\u00ae\u00a0esf\u00edncter urin\u00e1rio artificial no tratamento da incontin\u00eancia masculina\" \/>\n<meta property=\"og:description\" content=\"O estudo de Rigicon sobre ContiReflex\u00ae para incontin\u00eancia masculina mostra uma taxa de sobreviv\u00eancia de 98% em 18 meses, com revis\u00f5es m\u00ednimas, demonstrando sua seguran\u00e7a e efic\u00e1cia.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.rigicon.com\/pt-br\/comunicados-de-imprensa\/new-study-confirms-first-safety-outcomes-of-contireflex-artificial-urinary-sphincter-for-treating-male-incontinence\/\" \/>\n<meta property=\"og:site_name\" content=\"Rigicon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/rigiconurology\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-05-12T08:25:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.rigicon.com\/wp-content\/uploads\/2024\/05\/press-releases-detail-page-contireflex-d.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1440\" \/>\n\t<meta property=\"og:image:height\" content=\"720\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@rigiconurology\" \/>\n<meta name=\"twitter:site\" content=\"@rigiconurology\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/comunicados-de-imprensa\\\/new-study-confirms-first-safety-outcomes-of-contireflex-artificial-urinary-sphincter-for-treating-male-incontinence\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/comunicados-de-imprensa\\\/new-study-confirms-first-safety-outcomes-of-contireflex-artificial-urinary-sphincter-for-treating-male-incontinence\\\/\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"Novo estudo confirma os primeiros resultados de seguran\u00e7a do ContiReflex\u00ae\u00a0esf\u00edncter urin\u00e1rio artificial no tratamento da incontin\u00eancia masculina\",\"datePublished\":\"2024-05-12T08:25:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/comunicados-de-imprensa\\\/new-study-confirms-first-safety-outcomes-of-contireflex-artificial-urinary-sphincter-for-treating-male-incontinence\\\/\"},\"wordCount\":867,\"publisher\":{\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/comunicados-de-imprensa\\\/new-study-confirms-first-safety-outcomes-of-contireflex-artificial-urinary-sphincter-for-treating-male-incontinence\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.rigicon.com\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/press-releases-detail-page-contireflex-d.jpg\",\"articleSection\":[\"Comunicados de Imprensa\"],\"inLanguage\":\"pt-BR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/comunicados-de-imprensa\\\/new-study-confirms-first-safety-outcomes-of-contireflex-artificial-urinary-sphincter-for-treating-male-incontinence\\\/\",\"url\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/comunicados-de-imprensa\\\/new-study-confirms-first-safety-outcomes-of-contireflex-artificial-urinary-sphincter-for-treating-male-incontinence\\\/\",\"name\":\"ContiReflex AUS Safety Outcomes Study | Rigicon\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/comunicados-de-imprensa\\\/new-study-confirms-first-safety-outcomes-of-contireflex-artificial-urinary-sphincter-for-treating-male-incontinence\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/comunicados-de-imprensa\\\/new-study-confirms-first-safety-outcomes-of-contireflex-artificial-urinary-sphincter-for-treating-male-incontinence\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.rigicon.com\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/press-releases-detail-page-contireflex-d.jpg\",\"datePublished\":\"2024-05-12T08:25:00+00:00\",\"description\":\"O estudo de Rigicon sobre ContiReflex\u00ae para incontin\u00eancia masculina mostra uma taxa de sobreviv\u00eancia de 98% em 18 meses, com revis\u00f5es m\u00ednimas, demonstrando sua seguran\u00e7a e efic\u00e1cia.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/comunicados-de-imprensa\\\/new-study-confirms-first-safety-outcomes-of-contireflex-artificial-urinary-sphincter-for-treating-male-incontinence\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/comunicados-de-imprensa\\\/new-study-confirms-first-safety-outcomes-of-contireflex-artificial-urinary-sphincter-for-treating-male-incontinence\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/comunicados-de-imprensa\\\/new-study-confirms-first-safety-outcomes-of-contireflex-artificial-urinary-sphincter-for-treating-male-incontinence\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.rigicon.com\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/press-releases-detail-page-contireflex-d.jpg\",\"contentUrl\":\"https:\\\/\\\/www.rigicon.com\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/press-releases-detail-page-contireflex-d.jpg\",\"width\":1440,\"height\":720},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/comunicados-de-imprensa\\\/new-study-confirms-first-safety-outcomes-of-contireflex-artificial-urinary-sphincter-for-treating-male-incontinence\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Novo estudo confirma os primeiros resultados de seguran\u00e7a do ContiReflex\u00ae\u00a0esf\u00edncter urin\u00e1rio artificial no tratamento da incontin\u00eancia masculina\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/#website\",\"url\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/\",\"name\":\"Rigicon\",\"description\":\"Innovative Urological Solutions\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/#organization\"},\"alternateName\":\"Innovative Urological Solutions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/#organization\",\"name\":\"Rigicon, Inc.\",\"alternateName\":\"Innovative Urological Solutions\",\"url\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.rigicon.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/cropped-Logo-Square-Kopya.jpg\",\"contentUrl\":\"https:\\\/\\\/www.rigicon.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/cropped-Logo-Square-Kopya.jpg\",\"width\":512,\"height\":512,\"caption\":\"Rigicon, Inc.\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/rigiconurology\\\/\",\"https:\\\/\\\/x.com\\\/rigiconurology\",\"https:\\\/\\\/www.instagram.com\\\/rigiconurology\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@Rigicon\\\/podcasts\",\"https:\\\/\\\/www.youtube.com\\\/Rigicon\",\"https:\\\/\\\/www.threads.net\\\/@rigiconurology\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/rigicon\\\/\"],\"description\":\"Rigicon is a global provider of innovative, diverse, and complete portfolio of prosthetic urology options.\",\"email\":\"operations@rigicon.com\",\"telephone\":\"+1 (888) 202-9790\",\"legalName\":\"Rigicon, Inc.\",\"vatID\":\"81-3545645\",\"taxID\":\"81-3545645\",\"duns\":\"045247683\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"ContiReflex AUS Safety Outcomes Study | Rigicon","description":"O estudo de Rigicon sobre ContiReflex\u00ae para incontin\u00eancia masculina mostra uma taxa de sobreviv\u00eancia de 98% em 18 meses, com revis\u00f5es m\u00ednimas, demonstrando sua seguran\u00e7a e efic\u00e1cia.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.rigicon.com\/pt-br\/comunicados-de-imprensa\/new-study-confirms-first-safety-outcomes-of-contireflex-artificial-urinary-sphincter-for-treating-male-incontinence\/","og_locale":"pt_BR","og_type":"article","og_title":"Novo estudo confirma os primeiros resultados de seguran\u00e7a do ContiReflex\u00ae\u00a0esf\u00edncter urin\u00e1rio artificial no tratamento da incontin\u00eancia masculina","og_description":"O estudo de Rigicon sobre ContiReflex\u00ae para incontin\u00eancia masculina mostra uma taxa de sobreviv\u00eancia de 98% em 18 meses, com revis\u00f5es m\u00ednimas, demonstrando sua seguran\u00e7a e efic\u00e1cia.","og_url":"https:\/\/www.rigicon.com\/pt-br\/comunicados-de-imprensa\/new-study-confirms-first-safety-outcomes-of-contireflex-artificial-urinary-sphincter-for-treating-male-incontinence\/","og_site_name":"Rigicon","article_publisher":"https:\/\/www.facebook.com\/rigiconurology\/","article_published_time":"2024-05-12T08:25:00+00:00","og_image":[{"width":1440,"height":720,"url":"https:\/\/www.rigicon.com\/wp-content\/uploads\/2024\/05\/press-releases-detail-page-contireflex-d.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_creator":"@rigiconurology","twitter_site":"@rigiconurology","twitter_misc":{"Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/www.rigicon.com\/pt-br\/comunicados-de-imprensa\/new-study-confirms-first-safety-outcomes-of-contireflex-artificial-urinary-sphincter-for-treating-male-incontinence\/#article","isPartOf":{"@id":"https:\/\/www.rigicon.com\/pt-br\/comunicados-de-imprensa\/new-study-confirms-first-safety-outcomes-of-contireflex-artificial-urinary-sphincter-for-treating-male-incontinence\/"},"author":{"name":"","@id":""},"headline":"Novo estudo confirma os primeiros resultados de seguran\u00e7a do ContiReflex\u00ae\u00a0esf\u00edncter urin\u00e1rio artificial no tratamento da incontin\u00eancia masculina","datePublished":"2024-05-12T08:25:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.rigicon.com\/pt-br\/comunicados-de-imprensa\/new-study-confirms-first-safety-outcomes-of-contireflex-artificial-urinary-sphincter-for-treating-male-incontinence\/"},"wordCount":867,"publisher":{"@id":"https:\/\/www.rigicon.com\/pt-br\/#organization"},"image":{"@id":"https:\/\/www.rigicon.com\/pt-br\/comunicados-de-imprensa\/new-study-confirms-first-safety-outcomes-of-contireflex-artificial-urinary-sphincter-for-treating-male-incontinence\/#primaryimage"},"thumbnailUrl":"https:\/\/www.rigicon.com\/wp-content\/uploads\/2024\/05\/press-releases-detail-page-contireflex-d.jpg","articleSection":["Comunicados de Imprensa"],"inLanguage":"pt-BR"},{"@type":"WebPage","@id":"https:\/\/www.rigicon.com\/pt-br\/comunicados-de-imprensa\/new-study-confirms-first-safety-outcomes-of-contireflex-artificial-urinary-sphincter-for-treating-male-incontinence\/","url":"https:\/\/www.rigicon.com\/pt-br\/comunicados-de-imprensa\/new-study-confirms-first-safety-outcomes-of-contireflex-artificial-urinary-sphincter-for-treating-male-incontinence\/","name":"ContiReflex AUS Safety Outcomes Study | Rigicon","isPartOf":{"@id":"https:\/\/www.rigicon.com\/pt-br\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.rigicon.com\/pt-br\/comunicados-de-imprensa\/new-study-confirms-first-safety-outcomes-of-contireflex-artificial-urinary-sphincter-for-treating-male-incontinence\/#primaryimage"},"image":{"@id":"https:\/\/www.rigicon.com\/pt-br\/comunicados-de-imprensa\/new-study-confirms-first-safety-outcomes-of-contireflex-artificial-urinary-sphincter-for-treating-male-incontinence\/#primaryimage"},"thumbnailUrl":"https:\/\/www.rigicon.com\/wp-content\/uploads\/2024\/05\/press-releases-detail-page-contireflex-d.jpg","datePublished":"2024-05-12T08:25:00+00:00","description":"O estudo de Rigicon sobre ContiReflex\u00ae para incontin\u00eancia masculina mostra uma taxa de sobreviv\u00eancia de 98% em 18 meses, com revis\u00f5es m\u00ednimas, demonstrando sua seguran\u00e7a e efic\u00e1cia.","breadcrumb":{"@id":"https:\/\/www.rigicon.com\/pt-br\/comunicados-de-imprensa\/new-study-confirms-first-safety-outcomes-of-contireflex-artificial-urinary-sphincter-for-treating-male-incontinence\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.rigicon.com\/pt-br\/comunicados-de-imprensa\/new-study-confirms-first-safety-outcomes-of-contireflex-artificial-urinary-sphincter-for-treating-male-incontinence\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/www.rigicon.com\/pt-br\/comunicados-de-imprensa\/new-study-confirms-first-safety-outcomes-of-contireflex-artificial-urinary-sphincter-for-treating-male-incontinence\/#primaryimage","url":"https:\/\/www.rigicon.com\/wp-content\/uploads\/2024\/05\/press-releases-detail-page-contireflex-d.jpg","contentUrl":"https:\/\/www.rigicon.com\/wp-content\/uploads\/2024\/05\/press-releases-detail-page-contireflex-d.jpg","width":1440,"height":720},{"@type":"BreadcrumbList","@id":"https:\/\/www.rigicon.com\/pt-br\/comunicados-de-imprensa\/new-study-confirms-first-safety-outcomes-of-contireflex-artificial-urinary-sphincter-for-treating-male-incontinence\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/www.rigicon.com\/pt-br\/"},{"@type":"ListItem","position":2,"name":"Novo estudo confirma os primeiros resultados de seguran\u00e7a do ContiReflex\u00ae\u00a0esf\u00edncter urin\u00e1rio artificial no tratamento da incontin\u00eancia masculina"}]},{"@type":"WebSite","@id":"https:\/\/www.rigicon.com\/pt-br\/#website","url":"https:\/\/www.rigicon.com\/pt-br\/","name":"Rigicon","description":"Innovative Urological Solutions","publisher":{"@id":"https:\/\/www.rigicon.com\/pt-br\/#organization"},"alternateName":"Innovative Urological Solutions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.rigicon.com\/pt-br\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/www.rigicon.com\/pt-br\/#organization","name":"Rigicon, Inc.","alternateName":"Innovative Urological Solutions","url":"https:\/\/www.rigicon.com\/pt-br\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/www.rigicon.com\/pt-br\/#\/schema\/logo\/image\/","url":"https:\/\/www.rigicon.com\/wp-content\/uploads\/2024\/07\/cropped-Logo-Square-Kopya.jpg","contentUrl":"https:\/\/www.rigicon.com\/wp-content\/uploads\/2024\/07\/cropped-Logo-Square-Kopya.jpg","width":512,"height":512,"caption":"Rigicon, Inc."},"image":{"@id":"https:\/\/www.rigicon.com\/pt-br\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/rigiconurology\/","https:\/\/x.com\/rigiconurology","https:\/\/www.instagram.com\/rigiconurology\/","https:\/\/www.youtube.com\/@Rigicon\/podcasts","https:\/\/www.youtube.com\/Rigicon","https:\/\/www.threads.net\/@rigiconurology","https:\/\/www.linkedin.com\/company\/rigicon\/"],"description":"Rigicon is a global provider of innovative, diverse, and complete portfolio of prosthetic urology options.","email":"operations@rigicon.com","telephone":"+1 (888) 202-9790","legalName":"Rigicon, Inc.","vatID":"81-3545645","taxID":"81-3545645","duns":"045247683"}]}},"jetpack_featured_media_url":"https:\/\/www.rigicon.com\/wp-content\/uploads\/2024\/05\/press-releases-detail-page-contireflex-d.jpg","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.rigicon.com\/pt-br\/wp-json\/wp\/v2\/posts\/13974","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rigicon.com\/pt-br\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.rigicon.com\/pt-br\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.rigicon.com\/pt-br\/wp-json\/wp\/v2\/comments?post=13974"}],"version-history":[{"count":0,"href":"https:\/\/www.rigicon.com\/pt-br\/wp-json\/wp\/v2\/posts\/13974\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.rigicon.com\/pt-br\/wp-json\/wp\/v2\/media\/7215"}],"wp:attachment":[{"href":"https:\/\/www.rigicon.com\/pt-br\/wp-json\/wp\/v2\/media?parent=13974"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.rigicon.com\/pt-br\/wp-json\/wp\/v2\/categories?post=13974"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.rigicon.com\/pt-br\/wp-json\/wp\/v2\/tags?post=13974"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}